Additionally, CAFs can upregulate the expression of PD-1/PD-L1 and CTLA4/B7 in cancer cells and other cells within the TME to assist tumor cells in avoiding immune responses.[15,69] Therefore, CAFs may play an important role in mediating resistance to ICI immunotherapy in PCa. The gene discussed is CTLA4; the disease is posterior cortical atrophy.